APOTEX FDA Approval ANDA 211730

ANDA 211730

APOTEX

FDA Drug Application

Application #211730

Application Sponsors

ANDA 211730APOTEX

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAMUSCULAR50MG/ML0FULVESTRANTFULVESTRANT

FDA Submissions

UNKNOWN; ORIG1AP2021-06-11STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAO

CDER Filings

APOTEX
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211730
            [companyName] => APOTEX
            [docInserts] => ["",""]
            [products] => [{"drugName":"FULVESTRANT","activeIngredients":"FULVESTRANT","strength":"50MG\/ML","dosageForm":"INJECTABLE;INTRAMUSCULAR","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/11\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-06-11
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.